⌘K

Login Start Free

Home/Filings/4/0001213900-21-068212

4//SEC Filing

Johnson Shane Aaron 4

Accession 0001213900-21-068212

CIK 0001728328other

View on SEC.gov Company Profile

Filed

Dec 29, 7:00 PM ET

Accepted

Dec 30, 7:22 PM ET

Size

4.5 KB

Accession

0001213900-21-068212

Insider Transaction Report

Form 4

Period: 2021-12-30

InMed Pharmaceuticals Inc.INM

Johnson Shane Aaron

SVP, GM of BayMedica LLC

Transactions

Purchase
Common Stock
2021-12-30$1.33/sh+8,093$10,736→ 296,095 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

InMed Pharmaceuticals Inc.

CIK 0001728328

Entity typeother

Related Parties

1

filerCIK 0001889332

Filing Metadata

Form type: 4
Filed: Dec 29, 7:00 PM ET
Accepted: Dec 30, 7:22 PM ET
Size: 4.5 KB

View on SEC.gov